Curi Bio
Curi Bio is accelerating the discovery of next-generation medicines through the Curiverse™, unifying assay-ready iPSC-derived cells, automated high-throughput biosystems, and cloud-based data analytics for human-relevant drug discovery. The Curiverse brings together disease-specific cell models, the Mantarray™ and Nautilai Plus™ biosystem platforms, and the Pulse™ analytics engine to deliver human functional data across cardiac, skeletal muscle, and neuromuscular research. Our mission is to give researchers the tools to discover safer, more effective medicines.
